136 related articles for article (PubMed ID: 20126476)
1. Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients.
Gadji M; Fortin D; Tsanaclis AM; Garini Y; Katzir N; Wienburg Y; Yan J; Klewes L; Klonisch T; Drouin R; Mai S
Neoplasia; 2010 Feb; 12(2):183-91. PubMed ID: 20126476
[TBL] [Abstract][Full Text] [Related]
2. Three-Dimensional Nuclear Telomere Profiling as a Biomarker for Recurrence in Oligodendrogliomas: A Pilot Study.
Gadji M; Mathur S; Bélanger B; Jangamreddy JR; Lamoureux J; Tsanaclis AMC; Fortin D; Drouin R; Mai S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198352
[TBL] [Abstract][Full Text] [Related]
3. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
[TBL] [Abstract][Full Text] [Related]
4. Novel automated three-dimensional genome scanning based on the nuclear architecture of telomeres.
Klewes L; Höbsch C; Katzir N; Rourke D; Garini Y; Mai S
Cytometry A; 2011 Feb; 79(2):159-66. PubMed ID: 21265009
[TBL] [Abstract][Full Text] [Related]
5. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.
Chaddad A; Sabri S; Niazi T; Abdulkarim B
Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951
[TBL] [Abstract][Full Text] [Related]
6. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
[TBL] [Abstract][Full Text] [Related]
7. Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma.
Hung NA; Eiholzer RA; Kirs S; Zhou J; Ward-Hartstonge K; Wiles AK; Frampton CM; Taha A; Royds JA; Slatter TL
Mod Pathol; 2016 Mar; 29(3):212-26. PubMed ID: 26769142
[TBL] [Abstract][Full Text] [Related]
8. A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component.
Gadji M; Crous-Tsanaclis AM; Mathieu D; Mai S; Fortin D; Drouin R
Neuropathology; 2014 Apr; 34(2):170-8. PubMed ID: 24118308
[TBL] [Abstract][Full Text] [Related]
9. Potential clinical role of telomere length in human glioblastoma.
La Torre D; Aguennouz M; Conti A; Giusa M; Raffa G; Abbritti RV; Germano' A; Angileri FF
Transl Med UniSa; 2011 Sep; 1():243-70. PubMed ID: 23905037
[TBL] [Abstract][Full Text] [Related]
10. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme.
Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A
Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.
Leiss L; Mega A; Olsson Bontell T; Nistér M; Smits A; Corvigno S; Rahman MA; Enger PØ; Miletic H; Östman A
Glia; 2020 May; 68(5):979-988. PubMed ID: 31769546
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional telomere architecture of esophageal squamous cell carcinoma: comparison of tumor and normal epithelial cells.
Sunpaweravong S; Sunpaweravong P; Sathitruangsak C; Mai S
Dis Esophagus; 2016 May; 29(4):307-13. PubMed ID: 25625311
[TBL] [Abstract][Full Text] [Related]
14. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.
Czarnek N; Clark K; Peters KB; Mazurowski MA
J Neurooncol; 2017 Mar; 132(1):55-62. PubMed ID: 28074320
[TBL] [Abstract][Full Text] [Related]
15. Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric.
Neal ML; Trister AD; Cloke T; Sodt R; Ahn S; Baldock AL; Bridge CA; Lai A; Cloughesy TF; Mrugala MM; Rockhill JK; Rockne RC; Swanson KR
PLoS One; 2013; 8(1):e51951. PubMed ID: 23372647
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TRF1 Telomere Protein Impairs Tumor Initiation and Progression in Glioblastoma Mouse Models and Patient-Derived Xenografts.
Bejarano L; Schuhmacher AJ; Méndez M; Megías D; Blanco-Aparicio C; Martínez S; Pastor J; Squatrito M; Blasco MA
Cancer Cell; 2017 Nov; 32(5):590-607.e4. PubMed ID: 29136505
[TBL] [Abstract][Full Text] [Related]
17. Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients.
Peeken JC; Hesse J; Haller B; Kessel KA; Nüsslin F; Combs SE
Strahlenther Onkol; 2018 Jun; 194(6):580-590. PubMed ID: 29442128
[TBL] [Abstract][Full Text] [Related]
18. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tumor shape features for overall survival prognosis in glioblastoma multiforme patients.
Sanghani P; Ti AB; Kam King NK; Ren H
Surg Oncol; 2019 Jun; 29():178-183. PubMed ID: 31196485
[TBL] [Abstract][Full Text] [Related]
20. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
